Skip to main content

Table 1 Post drug administration adverse events experienced by individuals with co-infections of W. bancrofti and O. volvulus.

From: Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis

Clinical signs / symptoms

(score) Peak intensity*

Group A† (Albendazole + Ivermectin, n = 8) (no. of individuals with symptoms)

Group B† (Placebo, n = 7) (no. of individuals with symptoms)

Fever

1.0

3

0

Adenitis

2.0

1

0

Oedema

2.0

0

1

Palpitations

1.0

0

3

Pruritis

1.0

1

0

Headache

NA

0

0

Dizziness

NA

0

0

Itching

NA

0

0

Chills

NA

0

0

Lethargy

NA

0

0